跳至主要内容
临床试验/CTRI/2024/06/068254
CTRI/2024/06/068254招募中4 期

A prospective, interventional, randomised, two-arm, single centre study to evaluate the effect of ten-on-ten syrup on children with attention deficit hyperactivity disorder (ADHD).

Herba Neuva Implex Pvt. Ltd1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年6月15日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
Improvement in signs and symptoms of ADHD assessed using Vanderbilt assessment scale-parent version.

研究概览

简要总结

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by persistent pattern of inattention and/or hyperactivity-impulsivity, interfering with functioning and development. The global prevalence rate of ADHD is around 5–10% . Children with ADHD have significant adverse outcomes such as educational problems, difficult peer relationships and increased rates of motor vehicle accidents, accidental injuries, and substance misuse. Since past two decades, the research on ADHD in western population has been accelerating, yet research on ADHD in India is on the rise only since the last decade. Ten-on-ten syrup is such alternative treatment which is an over-the-counter product, with no alcohol, no sedation, non-habit forming brain wellness tonic which is free from heavy metals. The objective is to evaluate improvement in signs and symptoms of ADHD after using ten-on-ten syrup based on Vanderbilt Assessment Scale-parent version. This study is a prospective, interventional, randomised, two-arm, single centre study. The inclusion criteria for the study is children (of all genders and any religion) aged between 6-12 years who are diagnosed with mild to moderate ADHD. Exclusion criteria for the study includes, children less than 6 years and more than 12 years, children with Epilepsy and taking anti-epileptic medications. children with severe comorbid conditions like oppositional defiant disorder, conduct disorder, substance abuse, anxiety disorder, history of hypersensitivity or food allergy to components of omega 3/6, herbal supplements shall be elicited on medical history, Children taking anticoagulant medications like warfarin or aspirin and children with chronic systemic disease or other major psychiatric disorders. The duration of the study is six months. Study Intervention which is the Ten-on-ten syrup will be given to ADHD diagnosed children for duration of 6 months. Data parameters for the study include demographic details, physical assessment, Vanderbilt Assessment parent version scale and follow up scale-parent version scores. The outcome of the study is to evaluate the improvement in signs and symptoms of ADHD assessed using Vanderbilt assessment scale-parent version.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
6.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Children aged between 6-12 years who are diagnosed with mild to moderate ADHD.
  • Children irrespective of gender, religion, socio-economic status.
  • Patient’s parent/legal guardian who is ready to sign Consent Form.

排除标准

  • Children less than 6 years and more than 12 years.
  • Children with Epilepsy and taking anti-epileptic medications.
  • Children with severe comorbid conditions like oppositional defiant disorder, conduct disorder, substance abuse, anxiety disorder.
  • History of hypersensitivity or food allergy to components of omega 3/6, ( fish like salmon, mackerel, tuna, sardines, shellfish or flaxseed oil, Nuts and seeds such as flaxseed, chia seeds, and walnuts), herbal supplements shall be elicited on medical history.
  • Children taking anticoagulant medications like warfarin or aspirin.
  • Children with chronic systemic disease or other major psychiatric disorders.

结局指标

主要结局

Improvement in signs and symptoms of ADHD assessed using Vanderbilt assessment scale-parent version.

时间窗: 24 weeks

次要结局

未报告次要终点

研究者

发起方
Herba Neuva Implex Pvt. Ltd
申办方类型
Pharmaceutical industry-Global
责任方
Principal Investigator
主要研究者

Dr Omkar Hajirnis

Bhaktivedanta Hospital and Research Institute

研究点 (1)

Loading locations...

相似试验

尚未招募
不适用
Study to compare effect of Homoeopathic medicines given along with Cognitive Behavioural Therapy for Attention Deficit Hyperactive Disorder in adults
CTRI/2025/11/097630Department of Organon of Medicine, White Memorial Homoeo Medical College and Hospital60
进行中(未招募)
不适用
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapyPatients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.MedDRA version: 12.1Level: LLTClassification code 10064104Term: ADHD
EUCTR2010-019981-94-FIHUS/ Neuropsykiatrian poliklinikka30
招募中
不适用
The ADHD Kids´ Study for Children 9-12 Years of Age
NCT07379359University of Iceland100
已完成
不适用
Attention deficit hyperactivity disorder, developmental coordination disorder, and the cognitive orientation to daily occupational performance approach: Is there a role for diagnostic profiling and treatment to improve mental health outcomes?Developmental Coordination DisorderMental Health - Other mental health disordersPhysical Medicine / Rehabilitation - Occupational therapyAttention Deficit Hyperactivity Disorder
ACTRN12618001972213a Trobe University19
尚未招募
不适用
Improving ADHD Symptoms and Quality of Life Through Diet
NCT07376746University College Cork200